One step forward, two steps backward
- 3 October 2019
- journal article
- letter
- Published by Elsevier BV in Genetics in Medicine
- Vol. 22 (2), 441-442
- https://doi.org/10.1038/s41436-019-0660-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)Genetics in Medicine, 2019
- Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA SequencingJournal of Clinical Oncology, 2018
- Physicians’ perspectives on receiving unsolicited genomic resultsGenetics in Medicine, 2018
- “Not pathogenic until proven otherwise”: perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes ProjectGenetics in Medicine, 2018
- Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population WomenJNCI Journal of the National Cancer Institute, 2018
- Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2Nature Communications, 2017
- Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and GenomicsGenetics in Medicine, 2017
- Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germlineCDH1mutation carriersJournal of Medical Genetics, 2015
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingGenetics in Medicine, 2013
- Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General PopulationCancer Prevention Research, 2011